WHEN MINUTES MATTER
Live / Registered — Registered (as of 09 May 2023)
What this means for you
Registered since 09 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90833551
- Registration number
- 7049975
- Mark type
- Stylized text
- Filed
- 16 Jul 2021
- Published for opposition
- 17 May 2022
- Registered
- 09 May 2023
- Attorney of record
- Nate A. Garhart
Goods and services
- Class 005 — Pharmaceuticals: Blood products for medical purposes, namely, for the treatment and control of bleeding; Pathogen inactivated blood for medical use; pathogen inactivated blood products for medical use, namely, for the treatment and control of bleeding; Pathogen reduced blood products for use in connection with transfusions, namely, plasma, cryoprecipitate, fibrinogen complex, and cryoprecipitated fibrinogen complex products; Pathogen reduced blood products, namely, plasma, cryoprecipitate, fibrinogen complex, and cryoprecipitated fibrinogen complex products for medical use
Owner
- Cerus Corporation, Concord, CA, US
- Cerus Corporation, Concord, CA, US
- Cerus Corporation, Concord, CA, US
Prosecution history
- 25 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 09 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2023 — USE AMENDMENT FILED
- 03 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Mar 2023 — TEAS STATEMENT OF USE RECEIVED